Pulling SEC filings + quote and writing the call…

agilon health, inc.
Next earnings Aug 3, 2026 · consensus $-0.11 EPS, $1.45B rev
Last earnings +4.2% on 2026-05-06
Revenue declined -2.1% YoY.
agilon health, inc. shows $5.93B in FY2025 revenue (-2.1% YoY), a -6.6% net margin, and -308.8% ROE.
Sources: SEC EDGAR (CIK 0001831097, latest 10-Q filed 2026-05-06) · EODHD · as of 6/24/2026, 1:12:53 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.52B | $2.39B | $4.32B | $6.06B | $5.93B |
| Gross profit | — | — | — | — | — |
| Operating income | -$372M | -$105M | -$232M | -$292M | -$463M |
| Net income | -$406M | -$107M | -$263M | -$260M | -$391M |
| Diluted EPS | — | — | — | — | — |
| Net margin | -26.7% | -4.5% | -6.1% | -4.3% | -6.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1049 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-06-02 | Wulf John William Director | Award | 2.13K | |
| 2026-06-02 | WILLIAMS RONALD A Director | Award | 2.13K | |
| 2026-06-02 | McLoughlin Karen Director | Award | 2.13K | |
| 2026-06-02 | MCKENZIE DIANA Director | Award | 2.13K | |
| 2026-06-02 | Mansukani Sharad Director | Award | 2.13K | |
| 2026-06-02 | Battaglia Silvana Director | Award | 2.13K | |
| 2026-06-01 | Zamore Denise Chief Legal Officer | Tax | 485.00 @ $92.54 | $44.9K |
| 2026-05-24 | Gertsch Timothy Chief Accounting Officer | Tax | 8.00 @ $86.39 | $691.12 |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.